{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:42:55Z","timestamp":1782772975512,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>To describe the prevalence of depression among patients with primary systemic vasculitides (PSV); compare prevalence according to vasculitis type and against controls; and examine the impact of depression on PSV outcomes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We searched Medline, PubMed, Scopus and Web of Science using a predefined protocol in accordance with PRISMA guidelines. We included all studies that reported the prevalence or impact of depression in PSV. We also included polymyalgia rheumatica (PMR) given its association with giant cell arteritis (GCA). Meta-analyses of prevalence estimates were performed using random-effects models and reported as percentages (95% confidence interval).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We reviewed a total of 15 studies that described the prevalence of depression, categorised into small (<jats:italic>n<\/jats:italic>\u2009=\u200910) and large vessel vasculitis (<jats:italic>n<\/jats:italic>\u2009=\u20097). Pooled prevalence estimate for depression in a small vessel (predominantly ANCA-associated) vasculitis was 28% (95% CI 20\u201338%) with significant heterogeneity (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200993%). Depression prevalence in large-vessel vasculitis (Takayasu and GCA\/PMR) was 24% (95% CI 17\u201334%), again with significant heterogeneity (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200996%). One study reported 56% prevalence of depression in medium vessel disease. The prevalence of depression in small vessel vasculitis was higher than healthy controls. In these patients, depression and depressive symptoms were associated with poorer quality of life, adherence, and work disability, but not disease activity or damage.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Depression is highly prevalent among patients with primary systemic vasculitis and associated with poorer outcomes across a range of measures in studies of small vessel disease. Further studies are needed for depression in medium and large vessel vasculitides.<\/jats:p>\n<\/jats:sec>","DOI":"10.1007\/s00296-020-04611-7","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T04:33:35Z","timestamp":1591245215000},"page":"1215-1221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The prevalence and impact of depression in primary systemic vasculitis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0543-1657","authenticated-orcid":false,"given":"Bradley","family":"Pittam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashar E.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3558-7353","authenticated-orcid":false,"given":"Sizheng Steven","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"issue":"1","key":"4611_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1\u201311","journal-title":"Arthritis Rheum"},{"issue":"5 Suppl 51","key":"4611_CR2","first-page":"S94","volume":"26","author":"R Phillip","year":"2008","unstructured":"Phillip R, Luqmani R (2008) Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 26(5 Suppl 51):S94\u2013104","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"4611_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41584-020-0370-z","volume":"16","author":"F Buttgereit","year":"2020","unstructured":"Buttgereit F (2020) Views on glucocorticoid therapy in rheumatology: the age of convergence. Nat Rev Rheumatol 16(4):239\u2013246","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"4611_CR4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T et al (2016) EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75(9):1583\u20131594","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"4611_CR5","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1093\/rheumatology\/key224","volume":"57","author":"MJ Cook","year":"2018","unstructured":"Cook MJ, Bellou E, Bowes J, Sergeant JC, O\u2019Neill TW, Barton A et al (2018) The prevalence of co-morbidities and their impact on physical activity in people with inflammatory rheumatic diseases compared with the general population: results from the UK Biobank. Rheumatology 57(12):2172\u20132182","journal-title":"Rheumatology"},{"key":"4611_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1644-6","author":"S Zhao","year":"2018","unstructured":"Zhao S, Thong D, Miller N, Duffield SJ, Hughes DM, Chadwick L et al (2018) The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis. Arthritis Res Ther [Internet]. https:\/\/doi.org\/10.1186\/s13075-018-1644-6","journal-title":"Arthritis Res Ther [Internet]"},{"issue":"5","key":"4611_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/rheumatology\/kex528","volume":"57","author":"F Matcham","year":"2018","unstructured":"Matcham F, Davies R, Hotopf M, Hyrich KL, Norton S, Steer S et al (2018) The relationship between depression and biologic treatment response in rheumatoid arthritis: an analysis of the British Society for Rheumatology Biologics Register. Rheumatol Oxf Engl 57(5):835\u2013843","journal-title":"Rheumatol Oxf Engl"},{"issue":"5","key":"4611_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10067-013-2164-z","volume":"32","author":"DM Carpenter","year":"2013","unstructured":"Carpenter DM, Hogan SL, Devellis RF (2013) Predictors of medication non-adherence for vasculitis patients. Clin Rheumatol 32(5):649\u2013657","journal-title":"Clin Rheumatol"},{"issue":"10","key":"4611_CR9","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006\u20131012","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"4611_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/occmed\/kqu024","volume":"64","author":"AF Stern","year":"2014","unstructured":"Stern AF (2014) The hospital anxiety and depression scale. Occup Med Lond 64(5):393\u2013394","journal-title":"Occup Med Lond"},{"key":"4611_CR11","unstructured":"CESD-R: Center for Epidemiologic Studies Depression Scale Revised Online Depression Assessment\u202fCESD-R Explanation [Internet]. https:\/\/cesd-r.com\/cesdr\/. Cited 2020 Apr 16"},{"issue":"9","key":"4611_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606\u2013613","journal-title":"J Gen Intern Med"},{"issue":"6","key":"4611_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/acr.20442","volume":"63","author":"RA Hajj-Ali","year":"2011","unstructured":"Hajj-Ali RA, Wilke WS, Calabrese LH, Hoffman GS, Liu X, Bena J et al (2011) Pilot study to assess the frequency of fibromyalgia, depression, and sleep disorders in patients with granulomatosis with polyangiitis (Wegener\u2019s). Arthritis Care Res 63(6):827\u2013833","journal-title":"Arthritis Care Res"},{"issue":"2","key":"4611_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/rheumatology\/kex379","volume":"57","author":"L Li","year":"2018","unstructured":"Li L, Neogi T, Jick S (2018) A cohort study of comorbidity in patients with granulomatosis with polyangiitis. Rheumatol Oxf Engl 57(2):291\u2013299","journal-title":"Rheumatol Oxf Engl"},{"issue":"12","key":"4611_CR15","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1007\/s10067-019-04657-4","volume":"38","author":"J-D Yun","year":"2019","unstructured":"Yun J-D, Ha J, Kim S, Park HA, Yoo J, Ahn SS et al (2019) Predictor of depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis. Clin Rheumatol 38(12):3485\u20133491","journal-title":"Clin Rheumatol"},{"issue":"6","key":"4611_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/art.11471","volume":"49","author":"M Koutantji","year":"2003","unstructured":"Koutantji M, Harrold E, Lane SE, Pearce S, Watts RA, Scott DGI (2003) Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 49(6):826\u2013837","journal-title":"Arthritis Rheum"},{"issue":"11","key":"4611_CR17","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1002\/acr.22069","volume":"65","author":"PC Grayson","year":"2013","unstructured":"Grayson PC, Amudala NA, Mcalear CA, Leduc RL, Shereff D, Richesson R et al (2013) Illness perceptions and fatigue in systemic vasculitis: fatigue and illness perceptions in vasculitis. Arthritis Care Res 65(11):1835\u20131843","journal-title":"Arthritis Care Res"},{"issue":"10","key":"4611_CR18","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/rheumatology\/ket237","volume":"52","author":"P Brezinova","year":"2013","unstructured":"Brezinova P, Englbrecht M, Lovric S, S\u00e4mann A, Strauss B, Wolf G et al (2013) Coping strategies and depressiveness in primary systemic vasculitis\u2014what is their impact on health-related quality of life? Rheumatology 52(10):1856\u20131864","journal-title":"Rheumatology"},{"issue":"7","key":"4611_CR19","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/keq098","volume":"49","author":"N Basu","year":"2010","unstructured":"Basu N, Jones GT, Fluck N, MacDonald AG, Pang D, Dospinescu P et al (2010) Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology 49(7):1383\u20131390","journal-title":"Rheumatology"},{"issue":"4","key":"4611_CR20","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.lpm.2013.02.231","volume":"42","author":"A Mcclean","year":"2013","unstructured":"Mcclean A, Morgan M, Harper L, Basu N, Jones D, Bosch J (2013) Severe fatigue and psychological morbidity in ANCA-associated vasculitis. Presse Med 42(4):749\u2013750","journal-title":"Presse Med"},{"issue":"10","key":"4611_CR21","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1093\/rheumatology\/ket238","volume":"52","author":"N Yilmaz","year":"2013","unstructured":"Yilmaz N, Can M, Oner FA, Kalfa M, Emmungil H, Karadag O et al (2013) Impaired quality of life, disability and mental health in Takayasu\u2019s arteritis. Rheumatology 52(10):1898\u20131904","journal-title":"Rheumatology"},{"issue":"24","key":"4611_CR22","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.2169\/internalmedicine.52.0848","volume":"52","author":"F Alibaz-Oner","year":"2013","unstructured":"Alibaz-Oner F, Can M, Ilhan B, Polat O, Mumcu G, Direskeneli H (2013) Presence of fibromyalgia in patients with Takayasu\u2019s arteritis. Intern Med 52(24):2739\u20132742","journal-title":"Intern Med"},{"issue":"6","key":"4611_CR23","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s10067-017-3691-9","volume":"37","author":"A Vivekanantham","year":"2018","unstructured":"Vivekanantham A, Blagojevic-Bucknall M, Belcher J, Mallen CD, Hider SL, Clarkson K (2018) How common is depression in patients with polymyalgia rheumatica? Clin Rheumatol 37(6):1633\u20131638","journal-title":"Clin Rheumatol"},{"issue":"6","key":"4611_CR24","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s10067-017-3730-6","volume":"37","author":"A Cawley","year":"2018","unstructured":"Cawley A, Prior JA, Muller S, Helliwell T, Hider SL, Mallen CD et al (2018) Association between characteristics of pain and stiffness and the functional status of patients with incident polymyalgia rheumatica from primary care. Clin Rheumatol 37(6):1639\u20131644","journal-title":"Clin Rheumatol"},{"issue":"5","key":"4611_CR25","first-page":"753","volume":"56","author":"L Li","year":"2017","unstructured":"Li L, Neogi T, Jick S (2017) Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink. Rheumatol Oxf Engl 56(5):753\u2013762","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"4611_CR26","first-page":"45","volume":"117","author":"RA Hajj-Ali","year":"2019","unstructured":"Hajj-Ali RA, Saygin D, Ray E, Morales-Mena A, Messner W, Sundaram P et al (2019) Long-term outcomes of patients with primary angiitis of the central nervous system. Clin Exp Rheumatol 117(2):45\u201351 (37 Suppl)","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"4611_CR27","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00296-017-3904-1","volume":"38","author":"A Hinojosa-Azaola","year":"2018","unstructured":"Hinojosa-Azaola A, Jimenez-Gonzalez A, Alcocer-Castillejos N (2018) Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis. Rheumatol Int 38(4):631\u2013640","journal-title":"Rheumatol Int"},{"issue":"1","key":"4611_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/annrheumdis-2012-202750","volume":"73","author":"N Basu","year":"2014","unstructured":"Basu N, McClean A, Harper L, Amft EN, Dhaun N, Luqmani RA et al (2014) The characterisation and determinants of quality of life in ANCA associated vasculitis. Ann Rheum Dis 73(1):207\u2013211","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4611_CR29","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/rheumatology\/ket483","volume":"53","author":"N Basu","year":"2014","unstructured":"Basu N, Erwig LP, Reid DM, Macfarlane GJ, Jones GT, Mcclean A et al (2014) Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatol UK 53(5):953\u2013956","journal-title":"Rheumatol UK"},{"issue":"12","key":"4611_CR30","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1093\/rheumatology\/ket169","volume":"52","author":"F Matcham","year":"2013","unstructured":"Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatol Oxf Engl 52(12):2136\u20132148","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"4611_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10067-019-04734-8","volume":"39","author":"SS Zhao","year":"2020","unstructured":"Zhao SS, Miller N, Harrison N, Duffield SJ, Dey M, Goodson NJ (2020) Systematic review of mental health comorbidities in psoriatic arthritis. Clin Rheumatol 39(1):217\u2013225","journal-title":"Clin Rheumatol"},{"key":"4611_CR32","doi-asserted-by":"crossref","unstructured":"Zhang L, Fu T, Yin R, Zhang Q, Shen B (2017) Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. BMC Psychiatry [Internet] 17. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5310017\/. Cited 14 May 2020","DOI":"10.1186\/s12888-017-1234-1"},{"issue":"6","key":"4611_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/pcn.12826","volume":"73","author":"B Grygiel-Gorniak","year":"2019","unstructured":"Grygiel-Gorniak B, Limphaibool N, Puszczewicz M (2019) Cytokine secretion and the risk of depression development in patients with connective tissue diseases. Psychiatry Clin Neurosci 73(6):302\u2013316","journal-title":"Psychiatry Clin Neurosci"},{"issue":"14","key":"4611_CR34","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1001\/archinte.160.14.2101","volume":"160","author":"MR DiMatteo","year":"2000","unstructured":"DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160(14):2101\u20132107","journal-title":"Arch Intern Med"},{"key":"4611_CR35","unstructured":"Moots R, Campbell S (2014) Is psychological status related to symptom experience in Beh\u00e7et\u2019s syndrome? ACR Meet Abstr [Internet]. https:\/\/acrabstracts.org\/abstract\/is-psychological-status-related-to-symptom-experience-in-behcets-syndrome\/. Cited 18 Apr 2020"},{"issue":"3","key":"4611_CR36","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10067-014-2677-0","volume":"35","author":"P Anyfanti","year":"2016","unstructured":"Anyfanti P, Gavriilaki E, Pyrpasopoulou A, Triantafyllou G, Triantafyllou A, Chatzimichailidou S et al (2016) Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated. Clin Rheumatol 35(3):733\u2013739","journal-title":"Clin Rheumatol"},{"issue":"4","key":"4611_CR37","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3899\/jrheum.150068","volume":"43","author":"AE Ahmed","year":"2016","unstructured":"Ahmed AE, Lowe D, Kirton JA, O\u2019Brien MR, Mediana A, Frankland H et al (2016) Development of a rheumatology-specific patient concerns inventory and its use in the rheumatology outpatient clinic setting. J Rheumatol 43(4):779\u2013787","journal-title":"J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04611-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04611-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04611-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T23:30:56Z","timestamp":1622763056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04611-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4611"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04611-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,4]]},"assertion":[{"value":"21 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}